IP Library Granted Patent US 11,908,139
Granted Patent B1
US 11,908,139 · App. 18/352,097 · Granted Feb 20, 2024

Systems and methods for training a statistical model to predict tissue characteristics for a pathology image

Inventors: Andrew H. Beck (Brookline, MA); Aditya Khosla (Lexington, MA)
Assignee: PathAI, Inc.
G06T7/0014G06F16/5866G06F18/214G06F18/2193G06N5/046G06T7/194G16H10/20G16H50/20G16H50/50G06T2207/20081G06T2207/30004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,908,139
App. No.
18/352,097
Filed
Jul 13, 2023
Granted
Feb 20, 2024
Kind
B1
Examiner
PARK, EDWARD
Art Unit
2661
USPC
382/128
Abstract

In some aspects, the described systems and methods provide for a method for training a statistical model to predict tissue characteristics for a pathology image. The method includes accessing annotated pathology images. Each of the images includes an annotation describing a tissue characteristic category for a portion of the image. A set of training patches and a corresponding set of annotations are defined using an annotated pathology image. Each of the training patches in the set includes values obtained from a respective subset of pixels in the annotated pathology image and is associated with a corresponding patch annotation determined based on an annotation associated with the respective subset of pixels. The statistical model is trained based on the set of training patches and the corresponding set of patch annotations. The trained statistical model is stored on at least one storage device.

Claims (50)

1. A method for predicting an entity of interest for a pathology image, the method comprising, by one or more processors:

accessing a pathology image of a patient;

processing, using a trained deep learning model trained on a plurality of annotated images, the pathology image to determine tissue and cell characteristics for the pathology image;

extracting values for one or more features based on the tissue and cell characteristics for the pathology image;

predicting an entity of interest using the values for the one or more features, wherein the entity of interest includes one or more of patient response, tumor molecular characteristics, and patient clinical outcomes; and

outputting the predicted entity of interest associated with the patient for storing on at least one storage device.

2. The method of claim 1 , wherein processing, using the trained deep learning model, the pathology to determine the tissue and cell characteristics comprises:

using a first deep learning model to identify cells characteristics for the pathology image; and

using a second deep learning model to identify tissue characteristics for the pathology image.

3. The method of claim 1 , wherein the pathology image is a H&E whole slide image.

4. The method of claim 1 , wherein the predicted entity of interest comprises response to drug or therapy associated with the patient.

5. The method of claim 1 , wherein the predicted entity of interest comprises prognosis of cancer for the patient.

6. The method of claim 1 , wherein the predicted entity of interest comprises tumor molecular characteristics including genomic markers.

7. The method of claim 1 , wherein the values for one or more features comprise spatial features related to spatial distribution of cells, heterogeneity, and texture.

8. The method of claim 1 , wherein predicting the entity of interest is performed additionally using clinical metadata associated with the patient.

9. The method of claim 1 , wherein the plurality of annotated pathology images are annotated by human pathologists.

10. The method of claim 1 , further comprising displaying one or more annotations overlaid on the pathology image, the one or more annotations describing the determined tissue and cell characteristics for the pathology image.

11. The method of claim 1 , wherein outputting the predicted entity of interest comprises displaying a value indicating a measurement of patient response.

12. A system for predicting an entity of interest for a pathology image, the system comprising:

at least one computer hardware processor; and

at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform:

accessing a pathology image of a patient;

processing, using a trained deep learning model trained on a plurality of annotated images, the pathology image to determine tissue and cell characteristics for the pathology image;

extracting values for one or more features based on the tissue and cell characteristics for the pathology image;

predicting an entity of interest using the values for the one or more features, wherein the entity of interest includes one or more of patient response, tumor molecular characteristics, and patient clinical outcomes; and

outputting the predicted entity of interest associated with the patient for storing on at least one storage device.

13. The system of claim 12 , wherein processing, using the trained deep learning model, the pathology to determine the tissue and cell characteristics comprises:

using a first deep learning model to identify cells characteristics for the pathology image; and

using a second deep learning model to identify tissue characteristics for the pathology image.

14. The system of claim 12 , wherein the predicted entity of interest comprises response to drug or therapy associated with the patient.

15. The system of claim 12 , wherein the predicted entity of interest comprises prognosis of cancer for the patient.

16. The system of claim 12 , wherein the predicted entity of interest comprises tumor molecular characteristics including genomic markers.

17. The system of claim 12 , wherein the values for one or more features comprise spatial features related to spatial distribution of cells, heterogeneity, and texture.

18. The system of claim 12 , wherein predicting the entity of interest is performed additionally using clinical metadata associated with the patient.

19. The system of claim 12 , wherein the at least one computer hardware processor is further configured to perform:

causing to display one or more annotations overlaid on the pathology image, the one or more annotations describing the determined tissue and cell characteristics for the pathology image.

20. The system of claim 12 , wherein outputting the predicted entity of interest comprises causing to display a value indicating a measurement of patient response.

21. A non-transitory computer-readable medium containing instructions that, when executed, cause at least one computer hardware processor to perform:

accessing a pathology image of a patient;

processing, using a trained deep learning model trained on a plurality of annotated images, the pathology image to determine tissue and cell characteristics for the pathology image;

extracting values for one or more features based on the tissue and cell characteristics for the pathology image;

predicting an entity of interest using the values for the one or more features, wherein the entity of interest includes one or more of patient response, tumor molecular characteristics, and patient clinical outcomes; and

outputting the predicted entity of interest associated with the patient for storing on at least one storage device.

22. The non-transitory computer-readable medium of claim 21 , wherein processing, using the trained deep learning model, the pathology to determine the tissue and cell characteristics comprises:

using a first deep learning model to identify cells characteristics for the pathology image; and

using a second deep learning model to identify tissue characteristics for the pathology image.

23. The non-transitory computer-readable medium of claim 21 , wherein the predicted entity of interest comprises response to drug or therapy associated with the patient.

24. The non-transitory computer-readable medium of claim 21 , wherein the predicted entity of interest comprises prognosis of cancer for the patient.

25. The non-transitory computer-readable medium of claim 21 , wherein the predicted entity of interest comprises tumor molecular characteristics including genomic markers.

26. The non-transitory computer-readable medium of claim 21 , wherein the plurality of annotated pathology images are annotated by human pathologists.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 28, 2026
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT
To: PATHAI, INC.
Reel/Frame 075427/0613 →
SECURITY INTEREST Recorded Sep 22, 2025
From: PATHAI, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
Reel/Frame 072322/0631 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRESSPONDENCE DATA PREVIOUSLY RECORDED AT REEL: 065182 FRAME: 0042. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jan 4, 2024
From: BECK, ANDREW H.; KHOSLA, ADITYA
To: PATHAI, INC.
Reel/Frame 066189/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2023
From: BECK, ANDREW H.; KHOSLA, ADITYA
To: PATHAI, INC.
Reel/Frame 065182/0042 →
Continuity (6)
Continuation 17542746 · Dec 6, 2021
Continuation 16841827 · Apr 7, 2020
Continuation 16001855 · Jun 6, 2018
Provisional Application 62515772 · Jun 6, 2017
Provisional Application 62515779 · Jun 6, 2017
Provisional Application 62515795 · Jun 6, 2017
Cited By (2)
US 12,597,523 US 12,683,031